Skip to main content
. 2022 May 13;12:874712. doi: 10.3389/fonc.2022.874712

Figure 1.

Figure 1

Study design. ALK, anaplastic lymphoma kinase; aNSCLC, advanced non-small cell lung cancer; CGP, comprehensive genomic profiling; gen., generation; NLST, next-line systemic treatment; TKI, tyrosine kinase inhibitor.